Efgartigimod
argenx
[]
itp made it to the plenary #ash22 what hasn't made it to the plenary is some breakthrough on reducing costs of itp medications. efgartigimod looks enormously expensive. cool biological mechanisms don't impress with the associated financial toxicity.
Gen Heme and Thrombosis MD @uhn 
Assistant prof @uoftmedicine